Global, Value and Access Consultant/GV&A Consultant

  • 1234, Woodcliff Lake, New Jersey, United States
  • Contract

Company Description

Infotree’s approach to every employee and customer is based around making a positive impact. We focus on over-servicing, continuous improvement and a high-quality culture.  We’re passionate about making successful matches for our employees and customers across the globe. Infotree prides itself in our proven track record and innovative culture with 100% focus on the employees and customers.

Job Description

Description:

 

The Global Contractor– Oncology provides strategic market access/HTA strategies and HEOR input to the Oncology Business Unit Leadership Team to ensure patient and payer-centric product development. The Global Contractor, GV&A will drive the development and alignment of value proposition strategies with clinical, regulatory, medical affairs, and commercial/field team. The Global Contractor - Oncology will report to the Senior Global Director - Oncology.

The Global Contractor, GV&A will be responsible for Value and Access Strategies for key Client’s oncology products,) as well as new products and indications. In collaboration with Global Market Access Contractor will support reimbursement activities for key oncology products in all markets.

Developing and executing comprehensive global HE and HTA strategies and implementation plans in collaboration with the Global Market Access and the Regional Market Access partners.

Demonstrate strong technical abilities in SLR, ITC, NMA, economic modelling (BIM and CEA), real world evidence, patient-reported outcomes, and GVD execution, and vendor management.

This is a dynamic, experienced individual, with very strong presentation and technical skills, with 7-10 years’ experience in the field of health outcomes and health economics within a pharmaceutical company or consulting, who enjoys working as a team and is looking to work in a rewarding fast-growing therapy area.

Responsibilities Percent of Time
1. Strategic Input into Oncology Leadership Team / Product Development Plans
• Drive alignment across complex matrix of clinical, medical affairs, commercial and value & access functions as well as local country affiliates to deliver an integrated global payer perspective.
• Serve as the subject matter expert on HEOR, pricing and reimbursement at the leadership team and provide key input to the clinical development plan and global regulatory plans.
• Collaborate internally with clinical development, biostatistics, and medical affairs to ensure that strategically appropriate payer- and patient- relevant endpoints are include in phase 2-4 trials. Critically assess every protocol and provide recommendations on study designs, comparator selection and outcomes measures.
• Create and implement Patient Reported Outcomes strategy: recommendation for PRO selection in clinical trials, PRO SAP, FDA/EMA PRO submissions, utility analyses and publications.
• Provide HEOR and P&R input to development and launch teams.
• In collaboration with Clinical, Medical Affairs and Regulatory Affairs, develop clinical strategy early in product development that supports broad market access.
• Work with commercial areas and clinical affairs to gather feedback from key opinion leaders and understand global reimbursement pathways; Lead cross functional initiatives and collaborate with Medical Affairs, Clinical, R&D, local Market Access and Affiliates to ensure solid understanding of global payer markets and emerging stakeholders in the reimbursement area and translate reimbursement requirements into product specifications and assess potential reward and risk.
• Provide estimates of pricing & reimbursement expectations and necessary future HEOR investments for business development reviews and existing products.
• Monitor healthcare legislative changes and proactively modify product reimbursement and market access plans to manage; communicate impact and recommendations to the leadership team. 20%
1. Strategic Input into Oncology Leadership Team / Product Development Plans
• Drive alignment across complex matrix of clinical, medical affairs, commercial and value & access functions as well as local country affiliates to deliver an integrated global payer perspective.
• Serve as the subject matter expert on HEOR, pricing and reimbursement at the leadership team and provide key input to the clinical development plan and global regulatory plans.
• Collaborate internally with clinical development, biostatistics, and medical affairs to ensure that strategically appropriate payer- and patient- relevant endpoints are include in phase 2-4 trials. Critically assess every protocol and provide recommendations on study designs, comparator selection and outcomes measures.
• Create and implement Patient Reported Outcomes strategy: recommendation for PRO selection in clinical trials, PRO SAP, FDA/EMA PRO submissions, utility analyses and publications.
• Provide HEOR and P&R input to development and launch teams.
• In collaboration with Clinical, Medical Affairs and Regulatory Affairs, develop clinical strategy early in product development that supports broad market access.
• Work with commercial areas and clinical affairs to gather feedback from key opinion leaders and understand global reimbursement pathways; Lead cross functional initiatives and collaborate with Medical Affairs, Clinical, R&D, local Market Access and Affiliates to ensure solid understanding of global payer markets and emerging stakeholders in the reimbursement area and translate reimbursement requirements into product specifications and assess potential reward and risk.
• Provide estimates of pricing & reimbursement expectations and necessary future HEOR investments for business development reviews and existing products.
• Monitor healthcare legislative changes and proactively modify product reimbursement and market access plans to manage; communicate impact and recommendations to the leadership team. 20%
2. Value Evidence Generation
• Drive high quality evidence generation methodologies and execution of timely deliverables for the Oncology BU, in collaboration with Medical Affairs and Product Creation Unit.
• Develop comprehensive outcomes research plans to identify and address evidentiary gaps for pricing and reimbursement submissions, patient-reported outcomes submissions, and health policy submissions.
• Provide advice and guidance for best practice in evidence generation strategies and methodologies, including enabling external scientific advice, ensuring appropriate protocol review committee’s advice sought and incorporated.
• Conduct systematic literature reviews, comparative effectiveness assessments, and indirect treatment comparisons to identify areas of value differentiation, opportunities for strategic evidence generation.
• Develop economic models and reports both for cost-effectiveness and budget impact analyses, as well as strong understanding of economic modelling methods, extrapolations and sensitivity analyses
• Conduct ITC and NMA and comparative effectiveness analyses
• Conduct Real Work Evidence research including retrospective and prospective studies.
• Develop and execute an effective and resource-efficient publication plan in collaboration with the clinical, medical affairs, and publication teams 40%
3. Global Value Dossier
• Develop accurate, succinct, and life-cycle appropriate global value dossiers to prepare country market access leads for pricing & reimbursement submissions.
• Validate payer messaging and utility of deliverables through affiliate feedback and external research.
• Develop and effectively collaborate on clinically appropriate cost-effectiveness and budget impact models with Market Access team and regional stakeholders.
• Confirm structural accuracy and support the provision of model inputs.
• Develop appropriate value story training materials to expedite communication of key strategic data and messages to support optimal market access. 30%
4. Global Market Access
• In collaboration with Global Market Access – Oncology, support market access country affiliates in securing successful reimbursement of Client’s oncology products by innovative market access tactics.
• Review business development opportunities from a market access perspective ensuring the reimbursability and pricing potentials of the assessed opportunity.
• Inform ideas and options through effective engagement with external experts, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment, enabling more efficient evidence development and /or optimizing demonstration of differentiation for both discovery assets and later medicines in development.
• KOL engagement and management 10%
 

 

Qualifications

• Degree in medicine, pharmacy, life sciences, economics or statistics
• A postgraduate degree such as Masters, MPH, or PhD in the area of Health Outcomes/Health Economics
• Minimum of 7 years’ experience in health outcomes.
• Competence in carrying out a variety of HEOR studies using a range of standard techniques including PRO validation, SLRs, ITC, NMA, Survival analysis
• Hands on experience of economic modeling projects, and HTA relevant statistical methodologies
• Solid background in the design and conduct of Health Technology Assessments (HTA) in and proven record of achieving local market access and favorable pricing in HTA driven markets such as UK, Sweden, Canada, or Australia
• Strong Excel modelling skills
• Effective analytical/problem solving skills, including generation of original and innovative ideas and solutions
• Experience of the preparation and delivery of HE communications: abstracts, posters and presentations for scientific conferences; manuscripts for peer-reviewed journals
• Action-oriented, customer-focused, with effective prioritization, goal-setting and time management skills
• Experience in the design of claims analysis and observational studies is desirable
• Effective interpersonal skills; projection of professional image and credibility; teamwork oriented and inclusive
• Ability to work cross-functionally within teams

Additional Information

All your information will be kept confidential according to EEO guidelines.